{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T20:54:53Z","timestamp":1791147293690,"version":"4.1.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T00:00:00Z","timestamp":1654646400000},"content-version":"vor","delay-in-days":2684,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["1P01CA108671"],"award-info":[{"award-number":["1P01CA108671"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","exphem.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Hematology"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/j.exphem.2014.10.013","type":"journal-article","created":{"date-parts":[[2014,11,8]],"date-time":"2014-11-08T11:04:23Z","timestamp":1415444663000},"page":"100-109.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["C-X-C motif chemokine 12 influences the development of extramedullary hematopoiesis in the spleens of myelofibrosis patients"],"prefix":"10.1016","volume":"43","author":[{"given":"Xiaoli","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sool Yeon","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cing Siang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Roboz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald","family":"Hoffman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exphem.2014.10.013_bib1","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/j.exphem.2006.06.016","article-title":"Primitive hematopoietic cell populations reside in the spleen: Studies in the pig, baboon, and human","volume":"34","author":"Dor","year":"2006","journal-title":"Exp Hematol"},{"key":"10.1016\/j.exphem.2014.10.013_bib2","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/j.cell.2007.09.047","article-title":"Immunosurveillance by hematopoietic progenitor cells trafficking through blood, lymph, and peripheral tissues","volume":"131","author":"Massberg","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.exphem.2014.10.013_bib3","doi-asserted-by":"crossref","first-page":"3923","DOI":"10.1182\/blood-2007-08-078147","article-title":"Stem-cell ecology and stem cells in motion","volume":"111","author":"Papayannopoulou","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2014.10.013_bib4","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/S0301-472X(02)00883-4","article-title":"Current understanding of stem cell mobilization: the roles of chemokines, proteolytic enzymes, adhesion molecules, cytokines, and stromal cells","volume":"30","author":"Lapidot","year":"2002","journal-title":"Exp Hematol"},{"key":"10.1016\/j.exphem.2014.10.013_bib5","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/ni813","article-title":"G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4","volume":"3","author":"Petit","year":"2002","journal-title":"Nat Immunol"},{"key":"10.1016\/j.exphem.2014.10.013_bib6","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/S0021-9258(17)42339-8","article-title":"Cloning of a human seven-transmembrane domain receptor, LESTR, that is highly expressed in leukocytes","volume":"269","author":"Loetscher","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1016\/j.exphem.2014.10.013_bib7","doi-asserted-by":"crossref","first-page":"7612","DOI":"10.1158\/0008-5472.CAN-09-1823","article-title":"Correction of the abnormal trafficking of primary myelofibrosis CD34+ cells by treatment with chromatin-modifying agents","volume":"69","author":"Wang","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.exphem.2014.10.013_bib8","doi-asserted-by":"crossref","first-page":"4508","DOI":"10.1182\/blood-2004-08-3238","article-title":"Constitutive mobilization of CD34+ cells into the peripheral blood in idiopathic myelofibrosis may be due to the action of a number of proteases","volume":"105","author":"Xu","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2014.10.013_bib9","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.exphem.2007.10.001","article-title":"Altered SDF-1\/CXCR4 axis in patients with primary myelofibrosis and in the Gata1 low mouse model of the disease","volume":"36","author":"Migliaccio","year":"2008","journal-title":"Exp Hematol"},{"key":"10.1016\/j.exphem.2014.10.013_bib10","doi-asserted-by":"crossref","first-page":"3026","DOI":"10.1182\/blood-2008-06-158386","article-title":"Does primary myelofibrosis involve a defective stem cell niche? From concept to evidence","volume":"112","author":"Lataillade","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2014.10.013_bib11","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.bcmd.2007.01.003","article-title":"The expression of CXCR4 is down-regulated on the CD34+ cells of patients with myelofibrosis with myeloid metaplasia","volume":"38","author":"Rosti","year":"2007","journal-title":"Blood Cells Mol Dis"},{"key":"10.1016\/j.exphem.2014.10.013_bib12","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1634\/stemcells.2008-0377","article-title":"Hypermethylation of CXCR4 promoter in CD34+ cells from patients with primary myelofibrosis","volume":"26","author":"Bogani","year":"2008","journal-title":"Stem Cells"},{"key":"10.1016\/j.exphem.2014.10.013_bib13","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1600-0609.1989.tb01253.x","article-title":"The splenomegaly of myeloproliferative and lymphoproliferative disorders: splenic cellularity and vascularity","volume":"43","author":"Zhang","year":"1989","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.exphem.2014.10.013_bib14","series-title":"World Health Organization classification of tumors of hematopoietic and lymphoid tissues","article-title":"Chronic idiopathic myelofibrosis","author":"Thiele","year":"2001"},{"key":"10.1016\/j.exphem.2014.10.013_bib15","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1111\/j.1365-2141.2004.04829.x","article-title":"Spleen neoangiogenesis in patients with myelofibrosis with myeloid metaplasia","volume":"124","author":"Barosi","year":"2004","journal-title":"Br J Haematol"},{"key":"10.1016\/j.exphem.2014.10.013_bib16","doi-asserted-by":"crossref","first-page":"5972","DOI":"10.1182\/blood-2010-02-269696","article-title":"Sequential treatment of CD34+ cells from patients with primary myelofibrosis with chromatin-modifying agents eliminate JAK2V617F-positive NOD\/SCID marrow repopulating cells","volume":"116","author":"Wang","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2014.10.013_bib17","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.exphem.2006.11.012","article-title":"Polycythemia vera is not initiated by JAK2V617F mutation","volume":"35","author":"Nussenzveig","year":"2007","journal-title":"Exp Hematol"},{"key":"10.1016\/j.exphem.2014.10.013_bib18","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/j.exphem.2009.07.003","article-title":"Clonal analyses define the relationships between chromosomal abnormalities and JAK2V617F in patients with Ph-negative myeloproliferative neoplasms","volume":"37","author":"Wang","year":"2009","journal-title":"Exp Hematol"},{"key":"10.1016\/j.exphem.2014.10.013_bib19","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0165-4608(88)90029-5","article-title":"Transformation of polycythemia vera to acute nonlymphocytic leukemia accompanied by t (1;3)(p36;q21) karyotype","volume":"33","author":"Najfeld","year":"1988","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.exphem.2014.10.013_bib20","doi-asserted-by":"crossref","first-page":"3402","DOI":"10.1158\/0008-5472.CAN-09-3977","article-title":"The effect of CXCL12 processing on CD34+ cell migration in myeloproliferative neoplasms","volume":"70","author":"Cho","year":"2010","journal-title":"Cancer Res"},{"key":"10.1016\/j.exphem.2014.10.013_bib21","doi-asserted-by":"crossref","first-page":"6417","DOI":"10.1158\/0008-5472.CAN-07-0572","article-title":"Effects of chromatin-modifying agents on CD34+cells from patients with idiopathic myelofibrosis","volume":"67","author":"Shi","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.exphem.2014.10.013_bib22","doi-asserted-by":"crossref","first-page":"3428","DOI":"10.1074\/jbc.C600277200","article-title":"Erlotinib effectively inhibits JAK2V617F activity and polycythemia vera cell growth","volume":"282","author":"Li","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.exphem.2014.10.013_bib23","doi-asserted-by":"crossref","first-page":"3888","DOI":"10.1172\/JCI64397","article-title":"Spleens of myelofibrosis patients contain malignant hematopoietic stem cells","volume":"122","author":"Wang","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1016\/j.exphem.2014.10.013_bib24","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.yexcr.2003.12.003","article-title":"Integrin \u03b14\u03b21 involvement in stromal cell-derived factor-1\u03b1-promoted myeloma cell transendothelial migration and adhesion: role of cAMP and the actin cytoskeleton in adhesion","volume":"294","author":"Parmo-Caba\u00f1as","year":"2004","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.exphem.2014.10.013_bib25","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/(SICI)1097-0169(1999)43:4<269::AID-CM1>3.0.CO;2-5","article-title":"Rho-kinase (ROK) promotes CD44v(3,8\u201310)-ankyrin interaction and tumor cell migration in metastatic breast cancer cells","volume":"43","author":"Bourguignon","year":"1999","journal-title":"Cell Motil Cytoskeleton"},{"key":"10.1016\/j.exphem.2014.10.013_bib26","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1038\/nm1489","article-title":"Requirement for CD44 in homing and engraftment of BCR-ABL-expressing leukemic stem cells","volume":"12","author":"Krause","year":"2006","journal-title":"Nat Med"},{"key":"10.1016\/j.exphem.2014.10.013_bib27","doi-asserted-by":"crossref","first-page":"2976","DOI":"10.1182\/blood.V86.8.2976.2976","article-title":"Differentiation-associated changes in CD44 isoform expression during normal hematopoiesis and their alteration in chronic myeloid leukemia","volume":"86","author":"Ghaffari","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2014.10.013_bib28","doi-asserted-by":"crossref","first-page":"6662","DOI":"10.1073\/pnas.1121623109","article-title":"The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors","volume":"109","author":"Willingham","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.exphem.2014.10.013_bib29","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.4049\/jimmunol.174.4.2004","article-title":"Negative regulation of phagocytosis in macrophages by the CD47-SHPS-1 system","volume":"174","author":"Okazawa","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.exphem.2014.10.013_bib30","doi-asserted-by":"crossref","first-page":"3249","DOI":"10.1182\/blood.V98.12.3249","article-title":"Diagnostic and clinical relevance of the number of circulating CD34+ cells in myelofibrosis with myeloid metaplasia","volume":"98","author":"Barosi","year":"2001","journal-title":"Blood"},{"issue":"495","key":"10.1016\/j.exphem.2014.10.013_bib31","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nature11885","article-title":"Haematopoietic stem cells and early lymphoid progenitors occupy distinct bone marrow niches","volume":"14","author":"Ding","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2014.10.013_bib32","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1111\/j.1365-2141.2010.08527.x","article-title":"Splenectomy produces a rapid but transient decrease of the frequency of circulating CD34+ haematopoietic progenitor cells in primary myelofibrosis","volume":"152","author":"Massa","year":"2011","journal-title":"Br J Haematol"},{"key":"10.1016\/j.exphem.2014.10.013_bib33","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/leu.2008.299","article-title":"CXCR4 antagonists: targeting the microenvironment in leukemia and other cancers","volume":"23","author":"Burger","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2014.10.013_bib34","doi-asserted-by":"crossref","first-page":"7000","DOI":"10.4049\/jimmunol.169.12.7000","article-title":"Cell surface peptidase CD26\/dipeptidylpeptidase IV regulates CXCL12\/stromal cell-derived factor-1 \u03b1-mediated chemotaxis of human cord blood CD34+ progenitor cells","volume":"169","author":"Christopherson","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.exphem.2014.10.013_bib35","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0014-5793(98)00830-8","article-title":"Processing by CD26\/dipeptidyl-peptidase IV reduces the chemotactic and anti-HIV-1 activity of stromal-cell-derived factor-1\u03b1","volume":"432","author":"Proost","year":"1998","journal-title":"FEBS Lett"},{"key":"10.1016\/j.exphem.2014.10.013_bib36","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1089\/scd.2013.0524","article-title":"Identification and characterization of circulating variants of CXCL12 from human plasma: effects on chemotaxis and mobilization of hematopoietic stem and progenitor cells","volume":"23","author":"Richter","year":"2014","journal-title":"Stem Cells Dev"},{"key":"10.1016\/j.exphem.2014.10.013_bib37","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/j.exphem.2005.06.022","article-title":"MMP-2 is required for bone marrow stromal cell support of pro-B-cell chemotaxis","volume":"33","author":"Clutter","year":"2005","journal-title":"Exp Hematol"},{"key":"10.1016\/j.exphem.2014.10.013_bib38","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1097\/PAT.0b013e3283613dbf","article-title":"Upregulated expression of CXCl-12 in human spleens with extramdullary hematpoiesis","volume":"45","author":"Miwa","year":"2013","journal-title":"Pathology"}],"container-title":["Experimental Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X14007413?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X14007413?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T08:32:05Z","timestamp":1759566725000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301472X14007413"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["S0301472X14007413"],"URL":"https:\/\/doi.org\/10.1016\/j.exphem.2014.10.013","relation":{},"ISSN":["0301-472X"],"issn-type":[{"value":"0301-472X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"C-X-C motif chemokine 12 influences the development of extramedullary hematopoiesis in the spleens of myelofibrosis patients","name":"articletitle","label":"Article Title"},{"value":"Experimental Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exphem.2014.10.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 ISEH - International Society for Experimental Hematology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}